PRA Health Sciences任命FDA高级官员领导新的去中心化临床试验战略全球卓越中心
23 nov. 2020 14h28 HE
|
PRA Health Sciences, Inc.
北卡罗来纳州罗利市, Nov. 24, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc.（NASDAQ：PRAH）今天宣布任命Isaac...
PRA Health Sciences nombra alto funcionario de la FDA para liderar el nuevo Centro Global de Excelencia para la Estrategia de Ensayos Clínicos Descentralizados
23 nov. 2020 14h28 HE
|
PRA Health Sciences, Inc.
RALEIGH, CAROLINA DEL NORTE, Nov. 23, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) anunció hoy el nombramiento del Dr. Isaac Rodríguez-Chávez, PhD, MHS, MS, como vicepresidente...
PRA Health Sciences nomeia alto funcionário da FDA para liderar o novo Centro Global de Excelência da Estratégia de Testes Clínicos Descentralizados
23 nov. 2020 14h28 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Nov. 23, 2020 (GLOBE NEWSWIRE) -- A PRA Health Sciences, Inc. (NASDAQ: PRAH) anunciou hoje a nomeação de Isaac Rodriguez-Chávez, PhD, MHS, MS, como Vice-Presidente Sênior, Assuntos...
PRA Health Sciences appoints senior FDA official to lead new Global Center of Excellence for Decentralized Clinical Trial Strategy
19 nov. 2020 16h02 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C. , Nov. 19, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today the appointment of Isaac Rodriguez-Chavez, PhD, MHS, MS, as Senior Vice President,...
PRA Health Sciences, Inc. Reports Third Quarter 2020 Results and Updates Full Year 2020 Guidance
04 nov. 2020 16h01 HE
|
PRA Health Sciences, Inc.
Net new business of $737.9 million; representing growth of 10.2%; Net book-to-bill of 1.28 excluding reimbursement revenueNet new business of $986.0 million; Net book-to-bill of 1.35 including...
PRA Health Sciences to Report Third Quarter 2020 Earnings
07 oct. 2020 17h09 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Oct. 07, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its third quarter 2020 results after the market closes on Wednesday, November 4, 2020. The...
PRA Health Sciences dipilih oleh BARDA untuk menjadi ahli Rangkaian Kajian Klinikal yang eksklusifnya
07 oct. 2020 11h10 HE
|
PRA Health Sciences, Inc.
Dengan kontrak baharu, PRA akan membantu Lembaga Penyelidikan dan Pembangunan Lanjutan Bioperubatan (BARDA) dalam pembangunan langkah balas perubatan untuk kesihatan orang awam RALEIGH, N.C., Oct. ...
PRA 헬스사이언스, BARDA로부터 임상 연구 네트워크 회원사로 선정
07 oct. 2020 11h10 HE
|
PRA Health Sciences, Inc.
미국 노스캐롤라이나주 롤리, Oct. 08, 2020 (GLOBE NEWSWIRE) -- PRA 헬스사이언스(PRA Health Sciences, Inc. (NASDAQ:PRAH))는 미국 생물의약품첨단연구개발국(BARDA)으로부터 업데이트된 임상연구 네트워크(Clinical Studies Network) 회원사로 등록되었다고 밝혔다. 임상시험 계획 및...
PRA Health Sciences von BARDA als Mitglied des exklusiven Clinical Studies Network ausgewählt
07 oct. 2020 11h10 HE
|
PRA Health Sciences, Inc.
Mit dem neuen Vertrag wird PRA die Biomedical Advanced Research and Development Authority (BARDA) bei der Entwicklung medizinischer Maßnahmen für die öffentliche Gesundheit unterstützen RALEIGH,...
BARDA 選擇 PRA Health Sciences 作為為其專屬臨床研究網絡的成員
07 oct. 2020 11h10 HE
|
PRA Health Sciences, Inc.
新澤西州拉里市, Oct. 07, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) 今天宣佈公司已獲生物醫學高級研究和開發管理局 (BARDA) 選為最新臨床研究網絡 (CSN) 的成員。PRA 獲授予臨床試驗計劃和執行 (CTPE)...